Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Elvira Sanz named next president of Farmaindustria

Will lead Spanish pharma industry body for the new two years

Pfizer Spain Farmaindustria Elvira SanzSpanish pharmaceutical industry body Farmaindustria has selected Pfizer Spain's president and CEO Elvira Sanz to serve as its new president.

She will serve a two-year term and replaces Ferrer Grupo CEO Jordi Rementol, who took office in 2010.

Sanz has worked in the pharmaceutical industry for nearly 25 years, holding increasingly senior roles at Abelló, MSD, Roche and Cyanamid.

She became directorate general at Wyeth Spain in 2000 and was named president and CEO of Pfizer Spain in 2009.

Sanz takes up her new role at Farmaindustria at a time of increasing difficulties for the Spanish pharma industry, which has been hit hard by a series of government cost-containment measures and unpaid bills.

26th October 2012

From: Research, Sales, Marketing, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

Business in the USA
The pharma business environment in the US
Tighter regulations, more pricing controls and increased international competition will drive market improvements...
babylon virtual health service
VIDEO: Switching to a virtual health service
Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone...
Online Physician Communities
Is the pharma industry bad?
Surveys of doctors and the public suggest not...